Targeting Mycobacterium tuberculosis Persistence through Inhibition of the Trehalose Catalytic Shift
ACS Infectious Diseases · 12.04.2024 · 10 (4) · 1391-1404
DOI: 10.1021/acsinfecdis.4c00138 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 14.03.2024. Verfasst von Karishma Kalera und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is the leading cause of death worldwide by infectious disease. Treatment of Mtb infection requires a six-month course of multiple antibiotics, an extremely challenging regimen necessitated by Mtb's ability to form drug-tolerant persister cells. Mtb persister formation is dependent on the trehalose catalytic shift, a stress-responsive metabolic remodeling mechanism in which the disaccharide trehalose is liberated from cell surface glycolipids and repurposed as an internal carbon source to meet energy and redox demands. Here, using a biofilm-persister model, metabolomics, and cryo-electron microscopy (EM), we found that azidodeoxy- and aminodeoxy-d-trehalose analogues block the Mtb trehalose catalytic shift through inhibition of trehalose synthase TreS (Rv0126), which catalyzes the isomerization of trehalose to maltose. Out of a focused eight-member compound panel constructed by chemoenzymatic synthesis, the natural product 2-trehalosamine exhibited the highest potency and significantly potentiated first- and second-line TB drugs in broth culture and macrophage infection assays. We also report the first structure of TreS bound to a substrate analogue inhibitor, obtained via cryo-EM, which revealed conformational changes likely essential for catalysis and inhibitor binding that can potentially be exploited for future therapeutic development. Our results demonstrate that inhibition of the trehalose catalytic shift is a viable strategy to target Mtb persisters and advance trehalose analogues as tools and potential adjunctive therapeutics for investigating and targeting mycobacterial persistence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States.
- Biochemistry, Cell, and Molecular Biology Program, Central Michigan University, Mount Pleasant, Michigan 48859, United States.
- Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
- Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
- Department of Chemistry, University of Southern Maine, Portland, Maine 04104, United States.
ORCID-Profile: Rasangi Pathirage, Peter J Woodruff, Donald R Ronning, Benjamin M Swarts
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Kalera, K., Liu, R., Lim, J., Pathirage, R., Swanson, D. H., Johnson, U. G., Stothard, A. I., Lee, J. J., Poston, A. W., Woodruff, P. J., Ronning, D. R., Eoh, H., & Swarts, B. M. (2024). Targeting Mycobacterium tuberculosis Persistence through Inhibition of the Trehalose Catalytic Shift. ACS Infectious Diseases, 10(4), 1391-1404. https://doi.org/10.1021/acsinfecdis.4c00138
Vancouver
Kalera K, Liu R, Lim J, Pathirage R, Swanson DH, Johnson UG, et al. Targeting Mycobacterium tuberculosis Persistence through Inhibition of the Trehalose Catalytic Shift. ACS Infectious Diseases. 2024;10(4):1391-1404. doi:10.1021/acsinfecdis.4c00138
BibTeX
@article{Kalera2024,
author = {Kalera, Karishma and Liu, Rachel and Lim, Juhyeon and Pathirage, Rasangi and Swanson, Daniel H and Johnson, Ulysses G and Stothard, Alicyn I and Lee, Jae Jin and Poston, Anne W and Woodruff, Peter J and Ronning, Donald R and Eoh, Hyungjin and Swarts, Benjamin M},
title = {Targeting Mycobacterium tuberculosis Persistence through Inhibition of the Trehalose Catalytic Shift},
journal = {ACS Infectious Diseases},
year = {2024},
volume = {10},
number = {4},
pages = {1391--1404},
doi = {10.1021/acsinfecdis.4c00138}
}
EUVIMED